- Neutra (OTCPK:NTRR) said on Friday it had paused its previously announced acquisition of Mercury Clinical Research.
- NTRR added it had put the transaction on hold “due to some internal housekeeping that Neutra must resolve before moving forward.”
- The company said it plans to reopen the deal once the “internal issues” have been resolved through a renewed letter of intent.
- In the interim, Mercury has contracted NTRR services via the “Clinical Foundations” service model, the company added.
- NTRR added it had decided to merge VIVIS and Deity Wellness into one brand.
- Press Release
Source link
